BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Mar 26, 2001
 |  BioCentury  |  Strategy

Affymetrix, Oxford Gene cut a deal

Affymetrix Inc. finished clearing away the underbrush of its patent dispute with Oxford Gene Technology Ltd., announcing late Friday that it had settled all pending litigation with the U.K. company. The companies dropped lawsuits in the U.S. and U.K. as well as patent interference proceedings in Europe, leaving AFFX with a license to Oxford Gene's technology.

Oxford Gene (Oxford, U.K.) had been claiming that its array intellectual property, including U.S. Patent No. 5,700,637, were infringed by AFFX's DNA microarray products. Oxford Gene...

Read the full 392 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >